Dr Patricia Jaaks
Within the Translational Cancer Genomics group, Patricia works on large-scale combination drug screens in cancer cell lines to establish a combination drug screen analysis framework and to identify novel cancer therapies and genetic biomarkers of synergy.
Postdoctoral Fellow at the Wellcome Trust Sanger Institute
Awarded PhD from University of Zurich, Switzerland PhD project: 'The proprotein convertase furin is a key regulator of paediatric sarcoma malignancy', University Children's Hospital Zurich
Graduated from Imperial College London, UK, MSc Molecular Medicine
Graduated from University of Hamburg, Germany, BSc Molecular Life Sciences